{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:04:46Z","timestamp":1784016286283,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["202211003"],"award-info":[{"award-number":["202211003"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0112200"],"award-info":[{"award-number":["2023YFE0112200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nano.2026.102966","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:49:31Z","timestamp":1780292971000},"page":"102966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Superparamagnetic core-shell nanoparticles enable co-delivery of psoralen and paclitaxel for the treatment of triple-negative breast cancer"],"prefix":"10.1016","volume":"75","author":[{"given":"Manling","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Marcelina","family":"D\u00edaz Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulazim Hussain","family":"Asim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102966_bb0005","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1097\/JS9.0000000000001799","article-title":"Global biomarker trends in triple-negative breast cancer research: a bibliometric analysis","volume":"110","author":"Wang","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.nano.2026.102966_bb0010","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.apsb.2025.03.004","article-title":"USP51\/GRP78\/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells","volume":"15","author":"Ou","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2026.102966_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2024.11.025","article-title":"DNA tetrahedral nanoparticles: co-delivery of siOTUD6B\/DOX against triple-negative breast cancer","volume":"377","author":"Zhang","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102966_bb0020","article-title":"Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer","volume":"29","author":"Qiao","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2026.102966_bb0025","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.2147\/IJN.S517753","article-title":"Platelet membrane-coated poly (lactic-co-glycolic acid) nanoparticles as a targeting drug delivery system for multidrug-resistant breast cancer","volume":"20","author":"Song","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102966_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122703","article-title":"Enhancing paclitaxel efficacy with piperine-paclitaxel albumin nanoparticles in multidrug-resistant triple-negative breast cancer by inhibiting P-glycoprotein","volume":"15","author":"Xu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102966_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00432-024-05648-y","article-title":"Psoralen: a narrative review of current and future therapeutic uses","volume":"150","author":"Galiatsatos","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.nano.2026.102966_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30214167","article-title":"Coumarin derivatives as anticancer agents: mechanistic landscape with an emphasis on breast cancer","volume":"30","author":"Hacholli","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2026.102966_bb0045","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/21691401.2025.2566711","article-title":"Optimized PEGylated paclitaxel and 6-gingerol co-loaded liposomes induce G2\/M phase arrest and apoptosis in MDA-MB-231 breast and A549 lung cancer cells","volume":"53","author":"Thangavelu","year":"2025","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.nano.2026.102966_bb0050","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.2147\/OTT.S171601","article-title":"Extracts and components of Ficus carica leaves suppress survival, cell cycle, and migration of triple-negative breast cancer MDA-MB-231 cells","volume":"11","author":"Zhang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.nano.2026.102966_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1442700","article-title":"Anti-tumor effect and hepatotoxicity mechanisms of psoralen","volume":"15","author":"Meng","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.102966_bb0060","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1038\/s41598-022-17625-x","article-title":"Novel psoralen derivatives as anti-breast cancer agents and their light-activated cytotoxicity against HER2 positive breast cancer cells","volume":"12","author":"Aekrungrueangkit","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102966_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216846","article-title":"XBP1s activates METTL3\/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer","volume":"596","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2026.102966_bb0070","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","article-title":"Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.102966_bb0075","article-title":"Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102966_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.146937","article-title":"Construction of pH-responsive albumin nanoparticles loaded with baicalin and evaluation of their anti-breast cancer activity","volume":"322","author":"Meng","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102966_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2022.08.030","article-title":"Spheroplexes: hybrid PLGA-cationic lipid nanoparticles, for in vitro and oral delivery of siRNA","volume":"350","author":"Arruda","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102966_bb0090","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3762\/bjnano.15.118","article-title":"Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects","volume":"15","author":"Rahat","year":"2024","journal-title":"Beilstein J Nanotechnol"},{"key":"10.1016\/j.nano.2026.102966_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101305","article-title":"Stable polymer-lipid hybrid nanoparticles based on mcl-polyhydroxyalkanoate and cationic liposomes for mRNA delivery","volume":"16","author":"Shishlyannikov","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102966_bb0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/D1NH00179E","article-title":"Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy","volume":"6","author":"Chung","year":"2021","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.nano.2026.102966_bb0105","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1039\/D2TB02630A","article-title":"Ultrasmall superparamagnetic iron oxide nanoparticles for enhanced tumor penetration","volume":"11","author":"Feng","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2026.102966_bb0110","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1021\/acsnano.3c08335","article-title":"Superparamagnetic Iron oxide nanoparticles reprogram the tumor microenvironment and reduce lung cancer regrowth after crizotinib treatment","volume":"18","author":"Horvat","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102966_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010236","article-title":"Superparamagnetic iron oxide nanoparticles (SPION): from fundamentals to state-of-the-art innovative applications for cancer therapy","volume":"15","author":"Vangijzegem","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102966_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106054","article-title":"Superparamagnetic iron oxide nanoparticles in clinical applications: current status and future perspectives","volume":"122","author":"Guo","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nano.2026.102966_bb0125","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.xphs.2021.04.006","article-title":"Polymeric lipid hybrid nanoparticles as a delivery system enhance the antitumor effect of emodin in vitro and in vivo","volume":"110","author":"Liu","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102966_bb0130","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.2174\/1381612826666201120155558","article-title":"Strategies for preparing different types of lipid polymer hybrid nanoparticles in targeted tumor therapy","volume":"27","author":"Zhuang","year":"2021","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2026.102966_bb0135","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.2147\/IJN.S374293","article-title":"ICAM1-targeting theranostic nanoparticles for magnetic resonance imaging and therapy of triple-negative breast cancer","volume":"17","author":"Chen","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102966_bb0140","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5434","article-title":"Curcumin pretreatment attenuates myocardial ischemia\/reperfusion injury by inhibiting ferroptosis, autophagy and apoptosis via HES1","volume":"54","author":"Yuan","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.nano.2026.102966_bb0145","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2217\/nnm-2021-0241","article-title":"Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer","volume":"16","author":"Liu","year":"2021","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2026.102966_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120722","article-title":"Effect of paclitaxel\/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma","volume":"604","author":"Maleki","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102966_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/jebm.70037","article-title":"Comparative effectiveness of paclitaxel-containing regimens for treatment of triple-negative breast cancer: a network meta-analysis","volume":"18","author":"Niu","year":"2025","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.nano.2026.102966_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.nano.2026.102966_bb0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.actbio.2023.11.019","article-title":"Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer","volume":"173","author":"Li","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.102966_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/jfb14090437","article-title":"Lipid-polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery","volume":"14","author":"Jain","year":"2023","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.nano.2026.102966_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102966_bb0180","doi-asserted-by":"crossref","first-page":"13996","DOI":"10.1021\/acs.chemrev.1c00755","article-title":"Polymer-lipid hybrid materials","volume":"121","author":"Go","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2026.102966_bb0185","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.xphs.2021.11.021","article-title":"Microfluidic preparation of nanoparticles using poly(ethylene glycol)-distearoylphosphatidylethanolamine for solubilizing poorly soluble drugs","volume":"111","author":"Terada","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102966_bb0190","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.2147\/IJN.S321984","article-title":"Superparamagnetic Iron oxide nanoparticles: cytotoxicity, metabolism, and cellular behavior in biomedicine applications","volume":"16","author":"Wei","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102966_bb0195","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41565-025-01958-5","article-title":"Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications","volume":"20","author":"Vadovics","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2026.102966_bb0200","article-title":"Pluronic-F-127-passivated SnO(2) nanoparticles derived by using Polygonum cuspidatum root extract: synthesis, characterization, and anticancer properties","volume":"12","author":"Alzahrani","year":"2023","journal-title":"Plants (Basel)"},{"key":"10.1016\/j.nano.2026.102966_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082102","article-title":"Pluronic F-68 and F-127 based nanomedicines for advancing combination cancer therapy","volume":"15","author":"Khaliq","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102966_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121772","article-title":"Advances in lipid-polymer hybrid nanoparticles: design strategies, functionalization, oncological and non-oncological clinical prospects","volume":"18","author":"Jacob","year":"2025","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:25:01Z","timestamp":1784013901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S1549963426000675"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102966","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superparamagnetic core-shell nanoparticles enable co-delivery of psoralen and paclitaxel for the treatment of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102966"}}